Back
Cassava Sciences 10K Form
Sell
44
SAVA
Cassava Sciences
Last Price:
26.49
Seasonality Move:
47.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-12 | 10Q | SAVA/Cassava Sciences Quarterly |
| 2020-05-06 | 10Q | SAVA/Cassava Sciences Quarterly |
| 2020-03-26 | 10K | SAVA/Cassava Sciences Annual |
| 2019-10-29 | 10Q | SAVA/Cassava Sciences Quarterly |
| 2019-08-12 | 10Q | SAVA/Cassava Sciences Quarterly |
| 2019-05-02 | 10Q | SAVA/Cassava Sciences Quarterly |
Receive SAVA News And Ratings
See the #1 stock for the next 7 days that we like better than SAVA
SAVA Financial Statistics
Sales & Book Value
| Annual Sales: | $41.12M |
|---|---|
| Cash Flow: | $-18.31M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.47 |
| Price / Book: | 7.65 |
Profitability
| EPS (TTM): | -1.38000 |
|---|---|
| Net Income (TTM): | $-17.66M |
| Gross Margin: | $20.56M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Cassava Sciences Earnings Forecast
Key Cassava Sciences Financial Ratios
Cassava Sciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SAVA |
| CUSIP: | 14817C |
| Website: | cassavasciences.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SAVA Technical Analysis vs Fundamental Analysis
Sell
44
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy or a Sell?
-
Cassava Sciences stock is rated a Sell
The current Cassava Sciences [SAVA] share price is $26.48. The Score for SAVA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.